BCAB US Equity
BioAtla, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1826892 · FY ends Dec 31$3.27
+0.09 (+2.83%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 105K |
| % of shares out | 0.2% |
| Days to cover | 4.4 |
| Δ vs 2026-07-15 | -14.9% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 105,433 | -14.9% | 24,091 | 4.4 |
| 2026-07-15 | 123,939 | -18.4% | 64,576 | 1.9 |
| 2026-06-30 | 151,847 | -5.2% | 63,351 | 2.4 |
| 2026-06-15 | 160,104 | +8.4% | 70,806 | 2.3 |
| 2026-05-29 | 147,632 | -9.2% | 42,259 | 3.5 |
| 2026-05-15 | 162,567 | +10.4% | 29,605 | 5.5 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
